Compare TK & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TK | FLGT |
|---|---|---|
| Founded | 1973 | 2011 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.4M | 697.3M |
| IPO Year | 1995 | 2016 |
| Metric | TK | FLGT |
|---|---|---|
| Price | $9.18 | $28.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $28.33 |
| AVG Volume (30 Days) | ★ 604.1K | 252.7K |
| Earning Date | 10-29-2025 | 11-07-2025 |
| Dividend Yield | ★ 21.23% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $992,518,000.00 | $315,549,000.00 |
| Revenue This Year | N/A | $16.84 |
| Revenue Next Year | N/A | $9.74 |
| P/E Ratio | $10.67 | ★ N/A |
| Revenue Growth | N/A | ★ 13.61 |
| 52 Week Low | $5.65 | $14.57 |
| 52 Week High | $10.60 | $31.04 |
| Indicator | TK | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 56.59 |
| Support Level | $9.11 | $26.63 |
| Resistance Level | $9.43 | $31.04 |
| Average True Range (ATR) | 0.24 | 0.74 |
| MACD | -0.06 | -0.25 |
| Stochastic Oscillator | 13.48 | 54.59 |
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.